# Identification of Null Allelic Variant of CYP2C8 In A Korean Population

> **NCT01872780** · PHASE1 · COMPLETED · sponsor: **Inje University** · enrollment: 11 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rosiglitazone
- **GENETIC:** CYP2C8 genotype

## Key facts

- **NCT ID:** NCT01872780
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2013-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01872780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01872780, "Identification of Null Allelic Variant of CYP2C8 In A Korean Population". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01872780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*